Glenmark Pharmaceuticals Limited
Held by 235 mutual fund schemes, ₹8,655Cr between them.
The largest single position is HDFC Mid Cap Fund (HDFC), which holds 3.1% of its portfolio in Glenmark Pharmaceuticals Limited — ₹2,948Cr, or 34.1% of all the mutual fund money in this stock.
The five largest holders account for 48% of it, across 235 schemes in total.
15 of the 60 largest holdings sit in arbitrage funds, the most of any category here.
Funds holding Glenmark Pharmaceuticals Limited
235Largest rupee position first, top 60 shown. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
| Fund | Category | Weight | Position | Fund size |
|---|---|---|---|---|
| HDFC Mid Cap Fund | Mid Cap Fund | 3.07% | ₹2,948Cr | ₹96,040Cr |
| Invesco India Contra Fund | Contra Fund | 2.04% | ₹397.64Cr | ₹19,492Cr |
| ICICI Prudential Arbitrage Fund | Arbitrage Fund | 0.84% | ₹273.55Cr | ₹32,407Cr |
| Kotak Arbitrage Fund | Arbitrage Fund | 0.36% | ₹254.82Cr | ₹70,783Cr |
| HDFC Large & Mid Cap Fund | Large & Mid Cap Fund | 0.86% | ₹243.71Cr | ₹28,339Cr |
| HDFC Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.20% | ₹209.57Cr | ₹1,04,783Cr |
| Edelweiss Arbitrage Fund | Arbitrage Fund | 1.32% | ₹196.19Cr | ₹14,863Cr |
| Invesco India Arbitrage Fund | Arbitrage Fund | 0.65% | ₹180.82Cr | ₹27,818Cr |
| UTI - Arbitrage Fund | Arbitrage Fund | 1.64% | ₹179.40Cr | ₹10,939Cr |
| Bandhan Small Cap Fund | Small Cap Fund | 0.67% | ₹174.28Cr | ₹26,012Cr |
| Nippon India Arbitrage Fund | Arbitrage Fund | 0.99% | ₹162.17Cr | ₹16,381Cr |
| Mirae Asset Healthcare Fund | Sectoral/ Thematic | 4.99% | ₹150.48Cr | ₹3,017Cr |
| HDFC Manufacturing Fund | Sectoral/ Thematic | 1.44% | ₹147.48Cr | ₹10,241Cr |
| UTI Nifty 200 Momentum 30 Index Fund | Index Funds | 1.75% | ₹147.09Cr | ₹8,405Cr |
| Tata Mid Cap Fund | Mid Cap Fund | 2.38% | ₹134.48Cr | ₹5,650Cr |
| Aditya Birla Sun Life Arbitrage Fund | Arbitrage Fund | 0.51% | ₹133.32Cr | ₹26,029Cr |
| Mahindra Manulife Mid Cap Fund | Mid Cap Fund | 2.59% | ₹122.94Cr | ₹4,747Cr |
| HDFC Arbitrage Fund | Arbitrage Fund | 0.50% | ₹122.72Cr | ₹24,544Cr |
| UTI Value Fund | Value Fund | 1.30% | ₹121.50Cr | ₹9,346Cr |
| Edelweiss Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.91% | ₹117.35Cr | ₹12,896Cr |
| Bandhan Focused Fund | Focused Fund | 5.60% | ₹114.03Cr | ₹2,036Cr |
| Tata Arbitrage Fund | Arbitrage Fund | 0.50% | ₹113.42Cr | ₹22,684Cr |
| UTI - Mid Cap Fund | Mid Cap Fund | 0.87% | ₹102.11Cr | ₹11,737Cr |
| Axis Arbitrage Fund | Arbitrage Fund | 0.98% | ₹95.40Cr | ₹9,735Cr |
| Bandhan Arbitrage Fund | Arbitrage Fund | 1.11% | ₹90.06Cr | ₹8,114Cr |
| Mahindra Manulife Multi Cap Fund | Multi Cap Fund | 1.20% | ₹78.32Cr | ₹6,527Cr |
| Axis Multicap Fund | Multi Cap Fund | 0.80% | ₹78.20Cr | ₹9,775Cr |
| Mirae Asset Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.67% | ₹62.01Cr | ₹9,309Cr |
| Aditya Birla Sun Life Quant Fund | Sectoral/ Thematic | 2.94% | ₹59.66Cr | ₹2,033Cr |
| Mahindra Manulife Small Cap Fund | Small Cap Fund | 1.31% | ₹59.10Cr | ₹4,512Cr |
| Axis India Manufacturing Fund | Sectoral/ Thematic | 1.12% | ₹58.55Cr | ₹5,227Cr |
| Nippon India Nifty Pharma ETF | Other ETFs | 3.69% | ₹53.80Cr | ₹1,458Cr |
| HDFC Pharma and Healthcare Fund | Sectoral/ Thematic | 2.34% | ₹53.40Cr | ₹2,282Cr |
| DSP Arbitrage fund | Arbitrage Fund | 0.76% | ₹49.10Cr | ₹6,460Cr |
| Edelweiss Aggressive Hybrid Fund | Aggressive Hybrid Fund | 1.19% | ₹43.35Cr | ₹3,643Cr |
| Baroda BNP Paribas Arbitrage Fund | Arbitrage Fund | 3.38% | ₹42.25Cr | ₹1,250Cr |
| Edelweiss Nifty Midcap150 Momentum 50 Index Fund | Index Funds | 2.12% | ₹34.30Cr | ₹1,618Cr |
| Edelweiss Business Cycle Fund | Sectoral/ Thematic | 2.20% | ₹32.81Cr | ₹1,491Cr |
| HDFC Dividend Yield Fund | Dividend Yield Fund | 0.58% | ₹32.67Cr | ₹5,632Cr |
| HSBC Arbitrage Fund | Arbitrage Fund | 1.21% | ₹32.09Cr | ₹2,652Cr |
| UTI Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.49% | ₹31.90Cr | ₹6,510Cr |
| Motilal Oswal Nifty Midcap 150 Index Fund | Index Funds | 0.87% | ₹30.29Cr | ₹3,482Cr |
| Nippon India ETF Nifty Midcap 150 | Other ETFs | 0.88% | ₹29.71Cr | ₹3,377Cr |
| UTI - Healthcare Fund | Sectoral/ Thematic | 2.23% | ₹26.34Cr | ₹1,181Cr |
| Tata Nifty Midcap 150 Momentum 50 Index Fund | Index Funds | 2.13% | ₹24.40Cr | ₹1,145Cr |
| Bandhan Multi Cap Fund | Multi Cap Fund | 0.81% | ₹23.38Cr | ₹2,886Cr |
| Bandhan Innovation Fund | Sectoral/ Thematic | 1.03% | ₹22.16Cr | ₹2,151Cr |
| UTI Multi Asset Allocation Fund | Multi Asset Allocation | 0.32% | ₹21.97Cr | ₹6,867Cr |
| Nippon India Nifty Midcap 150 Index Fund | Index Funds | 0.88% | ₹21.09Cr | ₹2,396Cr |
| Baroda BNP Paribas Innovation Fund | Sectoral/ Thematic | 2.43% | ₹20.99Cr | ₹863.63Cr |
| Mahindra Manulife Business Cycle Fund | Sectoral/ Thematic | 1.58% | ₹20.50Cr | ₹1,297Cr |
| Kotak Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.12% | ₹20.38Cr | ₹16,987Cr |
| Nippon India Nifty 500 Momentum 50 Index Fund | Index Funds | 1.66% | ₹19.53Cr | ₹1,177Cr |
| Baroda BNP Paribas Health and Wellness Fund | Sectoral/ Thematic | 3.42% | ₹18.42Cr | ₹538.60Cr |
| Motilal Oswal Nifty 200 Momentum 30 Index Fund | Index Funds | 1.75% | ₹16.70Cr | ₹954.20Cr |
| Mirae Asset Arbitrage Fund | Arbitrage Fund | 0.45% | ₹16.48Cr | ₹3,657Cr |
| UTI Multi Cap Fund | Multi Cap Fund | 0.80% | ₹15.49Cr | ₹1,937Cr |
| Kotak Nifty Alpha 50 ETF | Other ETFs | 1.92% | ₹15.48Cr | ₹806.38Cr |
| Mirae Asset Nifty Midcap 150 ETF | Equity ETF | 0.87% | ₹14.96Cr | ₹1,714Cr |
| Bank of India Business Cycle Fund | Sectoral/ Thematic | 3.21% | ₹14.65Cr | ₹456.52Cr |
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM, available for 204 of the 235 holders. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Frequently asked questions
Which mutual fund holds the most Glenmark Pharmaceuticals Limited?
By rupee value, HDFC Mid Cap Fund from HDFC — ₹2,948Cr, at 3.1% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
Which fund has the highest weight in Glenmark Pharmaceuticals Limited?
Bandhan Focused Fund carries the largest weight at 5.6% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.
How many mutual funds hold Glenmark Pharmaceuticals Limited?
235 schemes, holding ₹8,655Cr between them across the 204 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding Glenmark Pharmaceuticals Limited make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.